Similar articles

• Prolymphocytic leukemia: treatment with combination chemotherapy to include doxorubicin.

  Taylor HG, Butler WM, Rhoads J, Karcher DS, Detrick-Hooks B. Taylor HG, et al. Cancer. 1982 Apr 15;49(8):1524-9. doi: 10.1002/1097-0142(19820415)49:8<1524::aid-cncr2820490803>3.0.co;2-u. Cancer. 1982. PMID: 6950800
• Prognostic factors in adult acute lymphoblastic leukemia.

  Lister TA, Roberts MM, Brearley RL, Cullen MH, Greaves MF. Lister TA, et al. Haematol Blood Transfus. 1979;23:99-105. doi: 10.1007/978-3-642-67057-2_12. Haematol Blood Transfus. 1979. PMID: 296119 No abstract available.
• Intermittent combined chemotherapy with doxorubicin in recurrent childhood acute lymphoblastic leukemia.

  Ward Platt MP, Mott MG, Eden OB. Ward Platt MP, et al. Med Pediatr Oncol. 1982;10(6):563-8. doi: 10.1002/mpo.2950100606. Med Pediatr Oncol. 1982. PMID: 6960230
• Prolymphocytic leukaemia.

  Catovsky D. Catovsky D. Nouv Rev Fr Hematol (1978). 1982;24(6):343-7. Nouv Rev Fr Hematol (1978). 1982. PMID: 6762526 Review.
• [Therapy of non-Hodgkin's lymphoma].

  Schaadt M, Plaumann L, Diehl V. Schaadt M, et al. Dtsch Med Wochenschr. 1984 Feb 17;109(7):261-5. doi: 10.1055/s-2008-1069178. Dtsch Med Wochenschr. 1984. PMID: 6199176 Review. German. No abstract available.